To clarify the serotonergic mechanisms involved in the protection agai
nst ischemic neuronal damage, ZD-211 (citalopram HBr), a serotonin (5-
hydroxytryptamine; 5-HT) re-uptake inhibitor, or buspirone, a 5-HT1A a
gonist, was locally administered into the hippocampus of gerbils. Addi
tionally, to clarify the role of the 5-HT nervous system in the hippoc
ampus during ischemic neuronal damage, animals were subjected to the l
ocal administration of 5,7-dihydroxytryptamine (5,7-DHT), a 5-HT neuro
toxin, before ischemia challenge. Gerbils received intrahippocampal ad
ministration of ZD-211 (200 nmol/animal) or buspirone (20 mnol/animal)
before 5-min ischemia, 5,7-DHT was intrahippocampally administered 7
days before a 2-min non-lethal ischemia challenge. In vehicle-treated
animals subjected to 5 min of ischemia, almost all hippocampal CA1 pyr
amidal neurons were lost. The treatment with ZD-211 or buspirone showe
d a significant protective effect, and the number of neurons was signi
ficantly increased compared to vehicle-treated animals. Pretreatment w
ith NAN-190, a 5-HT1A antagonist, completely abolished the protective
effect of ZD-211 or buspirone. In the 5,7-DHT-treated animals, the num
ber of neurons was significantly reduced following 2 min of ischemia c
ompared to vehicle-treated animals in which this period of ischemia is
non-lethal. Thus, intrahippocampal treatment with ZD-211 or buspirone
can protect neuronal damage following transient ischemia in gerbils.
These effects of ZD-211 and buspirone were mediated through the 5-HT1A
receptor in the hippocampus. Furthermore, the destruction of the 5-HT
nervous system in the hippocampus aggravated ischemic neuronal damage
. Therefore, this study showed that the enhanced activity of the 5-HT
nervous system in the hippocampus may protect against neuronal damage
following cerebral ischemia.